Cited by 40Abdominal vascular conditions and treatmentsAppendicitis Diagnosis and ManagementGastrointestinal Bleeding Diagnosis and Treatment

Endovascular interventions decrease length of hospitalization and are cost-effective in acute mesenteric ischemia

Open access
Erben, Young, Protack, Clinton D., Jean, Raymond A., Sumpio, Brandon J., Miller, Samuel M., Liu, Shirley, Trejo, Gerardo, Sumpio, Bauer E.·2018·Journal of Vascular Surgery

Abstract

Objective Acute mesenteric ischemia (AMI) continues to be one of the most devastating diagnoses requiring emergent vascular intervention. There is a national trend toward increased use of endovascular procedures, with improved survival for the treatment of these patients. Our aim was to evaluate whether this trend has changed the treatment of AMI and the subsequent impact on length of hospitalization and hospitalization costs.Methods We identified all patients admitted for AMI from the National Inpatient Sample from 2004 to 2014 who received open surgical revascularization (OPEN) or an endovascular intervention (ENDO). Primary end points included length of hospital stay and cost of hospitalization. Our secondary end points included acute kidney injury (AKI), in-hospital mortality, and routine discharge.Results Among 10,381 discharges identified in the data set, 3833 (37%; 97.5% confidence interval [CI], 35%-39%) were male patients with a mean age of 69 years (range, 18-98 years); 4543 (44%; 97.5% CI, 41%-47%) patients were treated ENDO, and 5839 (56%; 97.5% CI, 53%-59%) patients were treated OPEN. Although a higher proportion of patients in the ENDO group (28%; 97.5% CI, 24%-31%) vs the OPEN group (14%; 97.5% CI, 11%-16%) had a moderate to severe Charlson Comorbidity Index (P < .0001), ENDO was associated with a lower mortality rate (12.3% [97.5% CI, 9.8%-14.8%] vs 33.1% [97.5% CI, 29.9%-36.2%]; P < .0001) and a lower mean hospitalization cost ($41,615 [97.5% CI, $38,663-$44,567] vs $60,286 [97.5% CI, $56,736-$63,836]; P < .0001). After propensity-adjusted logistic regression analysis, OPEN retained a significant association with higher mortality than ENDO (odds ratio, 3.0; 97.5% CI, 2.2-4.1) and with higher costs (mean, $9196; 97.5% CI, $3797-$14,595). Patients in the OPEN group had higher risk for AKI (P < .0001) and discharge to a skilled nursing facility (P < .0001) rather than home.Conclusions Although the rate of ENDO continues to rise nationally, it still has not surpassed OPEN revascularization in the face of AMI. Patients treated endovascularly demonstrated one-third the rate of in-hospital mortality (odds ratio, 3.0; 97.5% CI, 2.2-4.1), an increased hazard ratio for discharge alive (hazard ratio, 2.27; 97.5% CI, 2.00-2.58), and a cost saving of $9196 (97.5% CI, $3797-$14,595) per hospitalization. Furthermore, they were less likely to develop AKI and to be discharged home after hospitalization.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2017.11.078

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Larger database analyses consistently show endovascular interventions are associated with improved postoperative morbidity and mortality, lower in-hospital mortality, lower bowel resection, decreased need for parenteral nutrition, shorter hospital stays, and lower cost compared to open surgery.

    “larger database analyses have consistently shown that these interventions are associated with improved postoperative morbidity and mortality, lower rates of in-hospital mortality, lower rates of bowel resection, decreased need for parenteral nutrition, shorter hospital stays, and lower cost compared to open surgery [53,74,75,76].”

    From Revascularization Strategies for Acute and Chronic Mesenteric Ischemia: A Narrative Review (2024) · cites this paper as [75]

    The Results (p. 5) report lower in-hospital mortality, bowel-resection rates, acute kidney injury, and hospitalization costs with endovascular treatment; the Discussion (p. 7) reports a shorter hospital stay. The paper does not report a decreased need for parenteral nutrition, and its postoperative-complication finding is specific to acute kidney injury rather than morbidity overall. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Endovascular treatment was associated with cost savings, whereas patients in the open group had a higher risk of acute kidney injury and were often discharged to a nursing facility rather than home.

    “In addition, endovascular treatment was associated with cost savings, whereas patients in the open group had a higher risk of acute kidney injury and were often discharged to a nursing facility rather than home. 161”
  • A nationwide analysis based on the US National Inpatient Sample showed a lower mortality rate for patients with AMI treated endovascularly compared with open revascularisation even though patients in the endovascular group had a higher comorbidity index.

    “A nationwide analysis based on the US National Inpatient Sample showed a lower mortality rate for patients with AMI treated endovascularly compared with open revascularisation even though patients in the endovascular group had a higher comorbidity index.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [15]15. [KarkkainenJM,AcostaS.Acutemesentericischemia(partII) d vascularandendovascularsurgicalapproaches.BestPractRes Clin Gastroenterol 2017;31:27-38.](http://refhub.elsevier.com/S0741-5214(18)30038-7/sref15)
  2. [21]21. [Kaschwich M, von Kodolitsch Y, Tsilimparis N, Behrendt CA, Sachweh A, Debus ES. [Vascular surgery in the elderly: what is possible? What is reasonable?]. Chirurg 2017;88:116.](http://refhub.elsevier.com/S0741-5214(18)30038-7/sref21)
  3. [28]28. [Leister I, Markus PM, Becker H. [Mesenteric ischemia. Is diagnostic laparoscopy of value?]. Chirurg 2003;74:407-12.](http://refhub.elsevier.com/S0741-5214(18)30038-7/sref28)
  4. [34]34. [Burgers LT, Vahl AC, Severens JL, Wiersema AM, Cuypers PW, VerhagenHJ,etal.Cost-effectivenessofelectiveendovascular aneurysm repair versus open surgical repair of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2016;52:29-40.](http://refhub.elsevier.com/S0741-5214(18)30038-7/sref34)

Cited by

Sorted by citations

Authors
Erben, Y., Protack, C. D., Jean, R. A., Sumpio, B. J., Miller, S. M., Liu, S., Trejo, G., & Sumpio, B. E.
Affiliations
  • Yale University (US)
  • Brown University (US)
Corresponding author
Erben, Young
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2018-08
Volume
68
Issue
2
Pages
459-469
ISSN
0741-5214 (ISSN-L)
OpenAlex
W2786317554
Cited by
40
References
40
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 5
FWCI
3.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Vascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (TL1TR001864)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
acute mesenteric ischemia, endovascular revascularization, open surgical revascularization, length of hospital stay, hospital costs, cost-effectiveness, in-hospital mortality, acute kidney injury, Charlson Comorbidity Index, National Inpatient Sample, propensity score matching, endovascular stent graft, mesenteric artery occlusion
MeSH terms
Acute Disease, Adolescent, Adult, Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Humans, Length of Stay, Male, Mesenteric Vascular Occlusion, Middle Aged, Patient Discharge, Retrospective Studies, Risk Factors, Splanchnic Circulation, Time Factors, United States, Vascular Surgical Procedures, Comorbidity, Multivariate Analysis, Linear Models, Logistic Models, Proportional Hazards Models, Odds Ratio, Databases, Factual, Treatment Outcome, Cost Savings, Hospital Mortality, Hospital Costs, Young Adult, Propensity Score, Endovascular Procedures, Acute Kidney Injury, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review